Incyte Corp (INCY)
70.39
-0.66
(-0.93%)
USD |
NASDAQ |
Nov 21, 16:00
70.35
-0.04
(-0.06%)
After-Hours: 20:00
Incyte Shareholders Equity (Quarterly): 3.171B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 3.171B |
June 30, 2024 | 2.997B |
March 31, 2024 | 5.394B |
December 31, 2023 | 5.190B |
September 30, 2023 | 4.931B |
June 30, 2023 | 4.741B |
March 31, 2023 | 4.463B |
December 31, 2022 | 4.370B |
September 30, 2022 | 4.227B |
June 30, 2022 | 4.085B |
March 31, 2022 | 3.863B |
December 31, 2021 | 3.770B |
September 30, 2021 | 3.149B |
June 30, 2021 | 2.936B |
March 31, 2021 | 2.728B |
December 31, 2020 | 2.611B |
September 30, 2020 | 2.391B |
June 30, 2020 | 2.345B |
March 31, 2020 | 1.938B |
December 31, 2019 | 2.598B |
September 30, 2019 | 2.423B |
June 30, 2019 | 2.247B |
March 31, 2019 | 2.086B |
December 31, 2018 | 1.926B |
September 30, 2018 | 1.803B |
Date | Value |
---|---|
June 30, 2018 | 1.733B |
March 31, 2018 | 1.628B |
December 31, 2017 | 1.631B |
September 30, 2017 | 1.758B |
June 30, 2017 | 1.027B |
March 31, 2017 | 965.93M |
December 31, 2016 | 419.47M |
September 30, 2016 | 369.99M |
June 30, 2016 | 297.06M |
March 31, 2016 | 227.75M |
December 31, 2015 | 171.16M |
September 30, 2015 | 88.74M |
June 30, 2015 | 55.17M |
March 31, 2015 | -41.41M |
December 31, 2014 | -81.63M |
September 30, 2014 | -89.59M |
June 30, 2014 | -171.00M |
March 31, 2014 | -162.42M |
December 31, 2013 | -193.11M |
September 30, 2013 | 28.79M |
June 30, 2013 | -27.79M |
March 31, 2013 | -163.53M |
December 31, 2012 | -174.96M |
September 30, 2012 | -219.95M |
June 30, 2012 | -217.19M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.938B
Minimum
Mar 2020
5.394B
Maximum
Mar 2024
3.595B
Average
3.471B
Median
Shareholders Equity (Quarterly) Benchmarks
Pfizer Inc | 92.29B |
Biomarin Pharmaceutical Inc | 5.413B |
Syndax Pharmaceuticals Inc | 366.43M |
Allogene Therapeutics Inc | 463.75M |
Arcutis Biotherapeutics Inc | 156.64M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 5.012B |
Total Liabilities (Quarterly) | 1.841B |
Current Ratio | 1.870 |